INCR
InterCure Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$4.46
−2.41%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.53x
- Price / sales
- 0.77x
- Price / cash flow
- 6.64x
Enterprise value
- Enterprise value
- $110.7M
- EV / sales
- 1.27x
- EV / EBITDA
- -6.53x
- EV / EBIT
- -12.64x
- Market cap
- $66.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025